Pfizer (PFE): FDA approves Tukysa regimen as first-line maintenance for HER2+ breast cancer
The FDA approved Pfizer's Tukysa with trastuzumab and pertuzumab as first-line maintenance for HER2-positive metastatic breast cancer. In the…
Pfizer (PFE)
1 take
All Centiview takes on Pfizer (ticker PFE): earnings, deals and market news, newest first. Filed under Healthcare; region: US. Each take lists its sources. For information only, not advice.